Appendix A
Workshop Agenda

Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: A Workshop


May 24, 2010


The Keck Center of the National Academies

500 Fifth Street, NW

Washington, DC 20001

MEETING OBJECTIVE

To examine and explore the access to, use of, and storage of dried blood spots that have been collected for newborn screening purposes through questions such as:

  • What are the benefits of making these resources available for translational research?

  • How do we protect the privacy and rights of individuals while allowing access to newborn screening samples?

  • How can we make these samples available without compromising the main function of the newborn screening program?

8:00–9:00 A.M.

WORKING BREAKFAST

9:00 A.M.

PUBLIC WORKSHOP BEGINS—KECK 100

9:00–9:10 A.M.

Welcome

 

Wylie Burke, Roundtable Chair, and Professor and Chair of the Department of Bioethics and Humanities, University of Washington



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 57
Appendix A Workshop Agenda Challenges and Opportunities in using Residual Newborn Screening Samples for Translational Research: A Workshop May 24, 2010 The keck Center of the National Academies 500 Fifth Street, NW Washington, DC 20001 MEETING OBJECTIVE To examine and explore the access to, use of, and storage of dried blood spots that have been collected for newborn screening purposes through questions such as: • What are the benefits of making these resources available for trans- lational research? • How do we protect the privacy and rights of individuals while allowing access to newborn screening samples? • How can we make these samples available without compromising the main function of the newborn screening program? 8:00–9:00 A.M. WORkING BREAkFAST 9:00 A.M. PuBLIC WORkSHOP BEGINS—kECk 100 Welcome 9:00–9:10 A.M. Wylie burke, Roundtable Chair, and professor and Chair of the Department of bioethics and Humanities, Uniersity of Washington 

OCR for page 57
 USING RESIDUAL NEWbORN SCREENING SAMpLES 9:10–10:20 A.M. CuRRENT STATuS REGARDING STORAGE OF NBS SAMPLES Current state practices and policies 9:10–9:30 A.M. Alissa Johnson, Johnson policy Consulting Rationale for storing newborn screening samples 9:30–9:50 A.M. Kenneth pass, Senior Research Scientist, New York State Department of Health Wadsworth Center Discussion 9:50–10:20 A.M. 10:20–10:30 A.M. BREAk 10:30 A.M.– RESEARCH OPPORTuNITIES ON 12:20 P.M. NBS SAMPLES Continuum from service to research 10:30–10:50 A.M. Anne Comeau, Deputy Director New England Newborn Screening program; Associate professor, Department of pediatrics, Uniersity of Massachusetts Medical School Opportunities for broader research 10:50–11:10 A.M. Sharon Kardia, professor and Chair of Epidemiology; Director, public Health Genetics program; Director, Life Science and Society program; Co-Director, Center for Genomics and public Health School of public Health, Uniersity of Michigan Implications of dataset linkage 11:10–11:30 A.M. Michele Caggana, Deputy Director Diision of Genetics; Chief, Laboratory of Human Genetics; Director, Newborn Screening program; Head, Genetic Testing Section, New York State Department of Health Wadsworth Center

OCR for page 57
 AppENDIX A Discussion 11:30 A.M.– 12:20 P.M. 12:20–1:20 P.M. WORkING LuNCH 1:20–3:30 P.M. SuRMOuNTING CHALLENGES Importance of retaining the core mission of new- 1:20–1:40 P.M. born screening programs Alan Fleischman, Medical Director, March of Dimes Foundation Balancing issues from the patient/parent 1:40–2:00 P.M. perspective Sharon Terry, president and CEO, Genetic Alliance Informed consent and stewardship 2:00–2:20 P.M. Kelly Edwards, Associate professor Department of bioethics and Humanities, Uniersity of Washington School of Medicine Legal issues related to the usage of newborn 2:20–2:40 P.M. screening samples Ellen Wright Clayton, Rosalind E. Franklin professor of Genetics and Health policy; Director, Center for biomedical Ethics and Society, Vanderbilt Uniersity Discussion 2:40–3:30 P.M. 3:30–3:45 P.M. Break 3:45–4:45 P.M. WEIGHING THE VALuE Panel discussion examining the potential benefits 3:45–4:45 P.M. that could be derived from the use of dried blood spots for translational research versus the issues that need to be overcome Ann Waldo, Senior Counsel, Genetic Alliance

OCR for page 57
0 USING RESIDUAL NEWbORN SCREENING SAMpLES Michele Caggana, New York State Department of Health Wadsworth Center Alan Fleischman, Medical Director, March of Dimes Foundation 4:45–5:30 P.M. SuMMARy AND WRAP-uP DISCuSSION Summary and wrap-up discussion 4:45–5:30 P.M. Wylie burke, Roundtable Chair and professor and Chair of the Department of bioethics and Humanities, Uniersity of Washington